SEARCH

SEARCH BY CITATION

References

  • 1
    Koo GC, Peppard JR, Mark WH. Natural killer cells generated from bone marrow culture. J Immunol 1984; 132: 23002304.
  • 2
    Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187376.
  • 3
    Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320: 17311735.
  • 4
    Rolstad B, Benestad HB. The “natural resistance” to bone marrow allografts in normal and athymic nude rats. Rapid cytotoxic reactions both in vivo and in vitro. Eur J Immunol 1984; 14: 793799.
  • 5
    Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987; 166: 14991509.DOI: 10.1084/jem.166.5.1499
  • 6
    Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165: 12121217.DOI: 10.1084/jem.165.4.1212
  • 7
    Gourlay WA, Chambers WH, Monaco AP, Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727734.DOI: 10.1097/00007890-199803150-00021
  • 8
    Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158: 56585667.
  • 9
    Krensky AM, Weiss A, Crabtree G, Davis MM, Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990; 322: 510517.
  • 10
    Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 18131821.DOI: 10.1056/NEJM199806183382506
  • 11
    Ogura Y, Martinez OM, Villanueva JC et al. Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation 2001; 71: 18271834.DOI: 10.1097/00007890-200106270-00020
  • 12
    Krams SM, Hayashi M, Fox CK et al. CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of small intestinal transplantation. J Immunol 1998; 160: 36733680.
  • 13
    Maier S, Tertilt C, Chambron N et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7: 557562.DOI: 10.1038/87880
  • 14
    Kondo T, Morita K, Watarai Y et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69: 969977.DOI: 10.1097/00007890-200003150-00051
  • 15
    Petersson E, Ostraat O, Ekberg H et al. Allogeneic heart transplantation activates alloreactive NK cells. Cell Immunol 1997; 175: 2532.DOI: 10.1006/cimm.1996.1031
  • 16
    Fuggle SV. Immunophenotypic analysis of leukocyte infiltration in the renal transplant. Immunol Lett 1991; 29: 143146.DOI: 10.1016/0165-2478(91)90216-W
  • 17
    Hsieh CL, Ogura Y, Obara H et al. Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts. Transplantation 2004; 77: 121128.DOI: 10.1097/01.TP.0000110423.27977.6F
  • 18
    Goddard S, Williams A, Morland C et al. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 2001; 72: 19571967.DOI: 10.1097/00007890-200112270-00016
  • 19
    Wang JD, Nonomura N, Takahara S et al. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. Immunology 1998; 95: 5661.DOI: 10.1046/j.1365-2567.1998.00570.x
  • 20
    Robertson H, Morley AR, Talbot D, Callanan K, Kirby JA. Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. Transplantation 2000; 69: 684687.DOI: 10.1097/00007890-200002270-00039
  • 21
    Adams DH, Hubscher S, Fear J, Johnston J, Shaw S, Afford S. Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation 1996; 61: 817825.DOI: 10.1097/00007890-199603150-00024
  • 22
    Lukacs NW, Hogaboam C, Campbell E, Kunkel SL. Chemokines: function, regulation and alteration of inflammatory responses. Chem Immunol 1999; 72: 102120.
  • 23
    Fairchild RL, VanBuskirk AM, Kondo T, Wakely ME, Orosz CG. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 1997; 63: 18071812.DOI: 10.1097/00007890-199706270-00018
  • 24
    Robinson LA, Nataraj C, Thomas DW et al. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 2000; 165: 60676072.
  • 25
    Fraticelli P, Sironi M, Bianchi G et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001; 107: 11731181.
  • 26
    Rollins BJ. Chemokines. Blood 1997; 90: 909928.
  • 27
    Miura M, Morita K, Kobayashi H et al. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 2001; 167: 34943504.
  • 28
    Morita K, Miura M, Paolone DR et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001; 167: 29792984.
  • 29
    Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002; 71: 173183.
  • 30
    Maghazachi AA, Al-Aoukaty A, Schall TJ. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.. J Immunol 1994; 153: 49694977.
  • 31
    Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998; 187: 114.DOI: 10.1084/jem.187.1.1
  • 32
    Salazar-Mather TP, Hamilton TA, Biron CA. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000; 105: 985993.
  • 33
    Egawa H, Martinez OM, Quinn MB et al. Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation 1995; 59: 97102.
  • 34
    Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 4750.
  • 35
    Hayashi M, Martinez OM, Krams SM, Burns W, Esquivel CO. Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg 1998; 2: 325332.DOI: 10.1016/S1091-255X(98)80071-1
  • 36
    Steiniger B, Stehling O, Scriba A, Grau V. Monocytes in the rat: phenotype and function during acute allograft rejection. Immunol Rev 2001; 184: 3844.DOI: 10.1034/j.1600-065x.2001.1840104.x
  • 37
    Matsuura A, Kinebuchi M, Chen HZ et al. NKT cells in the rat: organ-specific distribution of NK T cells expressing distinct V alpha 14 chains. J Immunol 2000; 164: 31403148.
  • 38
    Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993; 55: 329335.
  • 39
    Shirwan H, Cosenza CA, Wang HK, Wu GD, Makowka L, Cramer DV. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression. Transplantation 1994; 57: 10721080.
  • 40
    Baldwin WM, 3rd, Larsen CP, Fairchild RL. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001; 14: 369376.
  • 41
    Heidecke CD, Araujo JL, Kupiec-Weglinski JW et al. Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation 1985; 40: 441444.
  • 42
    Markus PM, Van Den Brink M, Cai X et al. Effect of selective depletion of natural killer cells on allograft rejection. Transplant Proc 1991; 23: 178179.
  • 43
    Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975980.DOI: 10.1084/jem.193.8.975
  • 44
    Jiang D, Liang J, Hodge J et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 2004; 114: 291299.DOI: 10.1172/JCI200416861
  • 45
    Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 2000; 164: 20092015.
  • 46
    Trambley J, Bingaman AW, Lin A et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 17151722.
  • 47
    Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 12601265.DOI: 10.1038/ni1138
  • 48
    Yamaguchi Y, Matsumura F, Liang J et al. Reduced interleukin-12, interleukin-18, and interferon-gamma production with prolonged rat hepatic allograft survival after donor-specific blood transfusion. Dig Dis Sci 2000; 45: 24292435.DOI: 10.1023/A:1005659529472
  • 49
    Stinn JL, Taylor MK, Becker G et al. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. Am J Pathol 1998; 153: 13831392.
  • 50
    Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3: 878884.DOI: 10.1034/j.1600-6143.2003.00132.x
  • 51
    Konieczny BT, Dai Z, Elwood ET et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 20592064.